Kawasaki disease is an acute illness of early childhood that is characterized by prolonged fever and vasculitis of unknown pathogenesis. Lactobacillus casei cell wall extract (LCWE)-induced vasculitis in mice is a well-validated model of Kawasaki disease. In the nervous system, glial cells play an important role in fever development. This study investigated whether LCWE directly stimulates glial cells, resulting in the induction of cyclooxygenase-2 (COX2), which is required for prostaglandin synthesis and fever development. We found that LCWE induced COX2 expression and activated the nuclear factor-kB signaling pathway in rat B92 glial cells, but Toll-like receptor-2, which is one of the receptors for LCWE, could not be detected in the cells. These results suggest that LCWE activates the nuclear factor-kB signaling pathway and induces COX2 in rat B92 glial cells through another LCWE receptor other than Toll-like receptor-2.
Introduction
Kawasaki disease, which is the most common cause of multisystem vasculitis with prolonged fever in childhood in eastern Asia, is always considered in the differential diagnosis of fever of unknown origin. 1 After a single intraperitoneal injection of Lactobacillus casei cell wall extract (LCWE), mice develop a focal and localized coronary arteritis that is histopathologically similar to the coronary artery lesions found in human Kawasaki disease. 2 Recent studies concerning signaling through Toll-like receptors (TLRs) in knockout mice have suggested that TLR2 signaling may play a role in LCWE-induced mouse Kawasaki disease. 2 However, the mechanisms of the pathogenesis and prolonged fever in Kawasaki disease have not yet been elucidated. Fever occurs due to the action of prostaglandin E2 (PGE2) mediated by cyclooxygenase-2 (COX2). Glial cells may play a crucial role in the production of PGE2 for developing fever in the brain. 3 This study investigated whether LCWE directly stimulates glial cells, resulting in the induction of COX2.
Methods and materials
LCWE fragments were obtained from L casei (ATCC 11578) as previously described. 4 Briefly, the bacterial cells were disrupted by overnight incubation in 4% sodium dodecyl sulfate in twice their packed volume. Cell wall fragment preparations were sonicated for 2 h. During sonication, the cell wall fragments were maintained at 4 C. After sonication, the cell wall fragments were centrifuged for 1 h at 20,000 Â g at 4 C, and the supernatant was retained. B92 rat glial cells, Chinese hamster ovary (CHO) cells, COS7 monkey kidney cells, and NIH3T3 mouse fibroblast cells were cultured in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal bovine serum (FBS), penicillin, and streptomycin at 37 C in 5% CO 2 . Proteins were extracted from the cells, and the protein concentrations were determined with protein assay reagents. Equal amounts of protein were separated by 10% sodium dodecyl sulfate-polyacrylamide gel electrophoresis. The resolved proteins were transferred to polyvinylidene fluoride membranes, which were incubated with primary antibodies (1:1000), followed by incubation with a horseradish peroxidase (HRP)-linked secondary antibody (1:2000) . The blots were developed with the Immobilon Western Chemiluminescence HRP Substrate (Millipore, Billerica, MA, USA).
Anti-phospho-specific nuclear factor (NF)-kB p65 (Ser536), anti-IkB-a, anti-phospho-specific p44/p42 MAPK (Thr202/ Tyr204), anti-b-actin, and HRP-linked anti-rabbit IgG were purchased from Cell Signaling Technology, Inc. (Danvers, MA, USA). Anti-COX2 and anti-NOD2 antibodies were obtained from Cayman Chemical Company (Ann Arbor, MI, USA). Anti-TRL2 antibody was obtained from Abnova Corporation (Taipei, Taiwan). TLR2 agonist (lipoteichoic acid) and NOD2 agonist (insoluble peptidoglycan) were purchased from InvivoGen (San Diego, CA, USA).
Results
First, we investigated whether LCWE induced COX2 expression in B92 glial cells. B92 cells were incubated in DMEM without FBS for 24 h and then treated with LCWE (10 mg/mL) for 16 h. Cell extracts were immunoblotted with anti-COX2 or anti-b-actin antibodies. LCWE treatment of B92 cells increased the levels of COX2 expression (Fig. 1A) . Next, to determine the effects of LCWE on the NF-kB signaling pathway, we investigated the levels of IkB-a and phospho-NF-kB after LCWE stimulation. B92 cells were incubated in DMEM without FBS for 24 h and then treated with LCWE (10 mg/mL) for 1 h. Cell extracts were immunoblotted with anti-IkB-a or phospho-NF-kB antibodies. LCWE decreased the levels of IkB-a expression and increased the levels of phospho-NF-kB expression (Fig. 1B) , indicating activation of the NF-kB signaling pathway in B92 glial cells.
Similarly to B92 cells, LCWE activated the NF-kB signaling pathway in CHO cells (Fig. 1C ) and COS7 cells (data not shown), but failed to induce the expression of COX2 in these cells (data not shown). Next, we investigated the levels of TLR2, which is thought to be the receptor of LCWE, 2 by immunoblotting with an anti-TLR2 antibody. Interestingly, TLR2 expression was detectable in COS7 cells, but the expression in B92 and CHO cells was below the limit of detection (Fig. 1D ). Our recent study demonstrated that LCWE activated NF-kB and p44/p42 MAPK in NIH3T3 mouse fibroblast cells, 5 in which TLR2 and COX2 expression was detectable (Figs. 2A and 2B). Although LCWE and the TLR2 agonist induced the activation of NF-kB and p44/p42 MAPK in this study (data not shown), LCWE and the TLR2 agonist failed to induce an upregulation of COX2 expression in NIH3T3 cells (Fig. 2B) .
The nucleotide binding and oligomerization domain (NOD)-like receptor (NLR) family is a major form of innate immune sensors, as is the TLR family.
6 NOD2 is critical for host defense against bacterial infection.
6,7 NOD2 acts as a cytoso sensor of distinct peptidoglycan fragments from both gram-negative and gram-positive bacteria. 6, 7 Interestingly, NOD expression was detectable in COS7, B92, and CHO cells (Fig. 1D) . Thus, we investigated whether a NOD2 agonist induced COX2 expression in B92 glial cells. Treatment with a NOD2 agonist, but not a TLR2 agonist, increased the levels of COX2 expression dose-dependently (Figs. 2C and 2D ). Similar to COX2 expression, a NOD2 agonist, but not a TLR2 agonist, activated p44/p42 MAPK in B92 cells (Fig. 2E) .
Discussion
Prostaglandins are crucial fever mediators in the central nervous system that act through the activation of prostaglandin receptors. 8 A recent study suggested that the induction of COX2 in glial cells plays an important role in producing PGE2 and developing fever.
3 LCWE induced the expression of COX2 in glial cells in this study (Fig. 1A) . However, the significance and mechanism of LCWE-induced COX2 expression is still unknown. Further studies are required to determine the role of LCWE in the induction of COX2 and developing fever in vivo.
Rat COX2 is encoded by a 5.7-kb genomic DNA segment with 10 exons. The 5 0 end of the flanking promoter region of rat COX2 contains multiple regulatory elements, including a putative NF-kB binding site, a CCAAT/enhancer binding proteinebinding site, and a cAMP-response element.
9,10
The NF-kB signaling pathway plays a crucial role in a variety of physiological and pathological events, including inflammation, immune responses, and apoptosis. In the canonical pathway, NF-kB proteins are bound to inhibitory molecules (IkBs) and sequestered in the cytoplasm in an inactive state. When cells are stimulated by appropriate factors, the IkB kinase (IKK) complex containing catalytically active IKKa and IKKb and the regulatory scaffold protein IKKg/NEMO phosphorylates IkB, leading to its ubiquitination and proteasomal destruction. NF-kB is subsequently released from inhibition to enter the nucleus where it can either repress or activate gene transcription. In human glial cells, the NF-kB element strongly alters COX2 promoter activity. 11 Our results in rat glial cells may be consistent with those in humans because LCWE activated the NF-kB signaling pathway and induced COX2 expression (Figs. 1A and 1B) . However, in other cells, the activation of the NF-kB signaling pathway was not sufficient for the induction of COX2. Although an LCWE agonist activated NF-kB signaling in CHO cells (Fig. 1C) , COS7 cells, and NIH3T3 cells (data not shown), LCWE failed to enhance the expression of COX2 in these cells in this study. These results indicated that the NF-kB signaling pathway might be necessary but not sufficient for COX2 induction under LCWE signaling.
The deletion of TLR2 failed to generate mouse Kawasaki disease by LCWE in TLR2 knockout mice, 2 suggesting that TLR2 is a receptor of LCWE. However, LCWE induced the activation of NF-kB signaling and the induction of COX2 in B92 cells in which TLR2 expression was not detected in this study (Fig. 1D) . Moreover, MAPK was activated by LCWE but not by a TLR2 agonist in B92 cells (Fig. 2E) . These results indicate the presence of other LCWE receptors other than TLR2 in B92 rat glial cells. NOD2, which is another innate immunoreceptor, was detected in both B92 and CHO cells (Fig. 2B) . NOD2 acts as a cytosolic sensor of distinct peptidoglycan fragments from both gram-negative and gram-positive bacteria. 6, 7 Once activated, NOD2 oligomerizes and recruits the NF-kB activating kinase RICK through homotypic CARD-CARD interactions involving their amino-terminal CARD motifs. RICK interacts with the regulatory scaffold protein IKKg/NEMO, triggering IkB phosphorylation and NF-kB activation. The cell walls of L casei are composed of peptidoglycan and associated uncharged polysaccharides, 12 and thus, LCWE are crude peptidoglycan preparations. In our study, a NOD2 agonist stimulated MAPK (Fig. 3 2E ) and the expression of COX2 dose-dependently (Fig. 2C) , suggesting that the actions of LCWE might be mimicked by a NOD2 agonist. Our results raise the possibility that NOD2 receptors are involved in the LCWE signaling pathway in B92 glial cells.
We showed here that LCWE activated NF-kB signaling independent of TLR2, but little is known about the physiological and pathological mechanisms of LCWE pathogenesis. Further studies are required to determine the role of the NLR family, including NOD1/2, in LCWE-mediated NF-kB signal activation. The levels of phospho-MAPK protein expression were evaluated by Western blotting in whole-cell lysates prepared from B92 cells treated with LCWE, TLR2 agonist, or NOD2 agonist for 1 h.
